Timing and Characteristics of Drug Resistance Mutations (DRMs) in Chronic Hepatitis C Patients During and After Treatment with Protease Inhibitor Therapy at a Single Centre

C. Velazquez, M. Macartney, D. Irish, S. Tanwar, P. Trembling, B. Hogan, J. Catt, S. Glasgow, M. Ju, M.t. Moore, M. Hains, B. Smith, D. Suri, M.g. Jacobs, J. Oben, P. Smith, C. Booth, S. Bridge, A. Garcia, A. MccormickE. Nastouli, G.M. Dusheiko, W. Rosenberg, T. Haque

Research output: Contribution to journalArticlepeer-review

Original languageEnglish
Pages (from-to)S497
JournalJournal of Hepatology
Publication statusPublished - 1 Apr 2013

Cite this